Beryl Drugs Q3 Results

  • BSE: 524606
  • NSE: -
  • ISIN: INE415H01017
  • Sector: Biotechnology & Drugs
BSE
33.10.57 (1.75%)
Volume212.00
Updated: Tue 26 Nov, 2024 | 09:07:13
NSE
This stock is not traded on NSE
Today: 33.10
33.10
52-Wk: 20.19
46.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Beryl Drugs Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 7.628.03-%8.15-%
    Selling/ General/ Admin Expenses Total 0.550.45-%0.47-%
    Depreciation/ Amortization 0.310.29-%0.22-%
    Other Operating Expenses Total 3.113.59-%2.86-%
    Total Operating Expense 7.177.66-%7.70-%
    Operating Income 0.450.36-%0.46-%
    Net Income Before Taxes 0.380.33-%0.38-%
    Net Income 0.310.27-%0.14-%
    Diluted Normalized EPS 0.610.54-%0.28-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts